Rujia Wang

机构：Microsoft (United States) · ORCID：0000-0001-5288-0503

发表论文 18 篇 · 总被引 162 次 · h-index 7

代表论文

• Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease (2022 · Lara D. Veeken · 被引 75)
• The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China (2020 · Frontiers in Oncology · 被引 19)
• Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease (2022 · Frontiers in Immunology · 被引 15)
• The frequency of imaging markers adjusted for time since symptom onset in intracerebral hemorrhage: A novel predictor for hematoma expansion (2023 · International Journal of Stroke · 被引 13)
• Poly-Drug Use of Prescription Medicine among People with Opioid Use Disorder in China: A Systematic Review and Meta-Analysis (2017 · Substance Use & Misuse · 被引 11)
• Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease (2024 · RMD Open · 被引 8)